Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.

Literature DB >> 2751289

Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.

Abstract

Ceftibuten is a new orally active cephalosporin with significant bioavailability. Its in vitro activity was compared with those of other agents against 383 strains of enteric pathogens derived from clinical specimens. Ceftibuten was very active against the strains of the family Enterobacteriaceae tested (overall MIC for 90% of strains tested, 0.25 microgram/ml) but was less active against Campylobacter jejuni (MIC for 90% of strains, 16 micrograms/ml). The MBC was one to two dilutions higher than the corresponding MICs for most pathogens tested.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1989 PMID： 2751289 PMCID： PMC172535 DOI： 10.1128/AAC.33.5.781

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

23 in total

Review 1. Antibiotic tolerance among clinical isolates of bacteria.

Authors: S Handwerger; A Tomasz
Journal: Rev Infect Dis Date: 1985 May-Jun

2. Drug resistance in Shigella dysenteriae, S flexneri and S boydii in England and Wales: increasing incidence of resistance to trimethoprim.

Authors: R J Gross; E J Threlfall; L R Ward; B Rowe
Journal: Br Med J (Clin Res Ed) Date: 1984-03-10

Review 3. Antibiotic resistance of Salmonella in Europe and the United States.

Authors: C E Cherubin
Journal: Rev Infect Dis Date: 1981 Nov-Dec

4. Bacteriological comparison of the activities of ceftriaxone, a new long-acting cephalosporin, with those of other new cephalosporins.

Authors: M Arisawa; J Ohshima; E Ohsawa; H B Maruyama; Y Sekine; S Mitsuhashi
Journal: Chem Pharm Bull (Tokyo) Date: 1982-07 Impact factor: 1.645

5. The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.

Authors: A von Graevenitz; C Bucher
Journal: Infection Date: 1982 Sep-Oct Impact factor: 3.553

6. Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.

Authors: L J Goodman; R M Fliegelman; G M Trenholme; R L Kaplan
Journal: Antimicrob Agents Chemother Date: 1984-04 Impact factor: 5.191

7. In-vitro susceptibility of salmonellae to antimicrobial agents.

Authors: H Goossens; R Vanhoof; P De Mol; O Grados; G Ghysels; J P Butzler
Journal: J Antimicrob Chemother Date: 1984-06 Impact factor: 5.790

8. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.

Authors: J R Carlson; S A Thornton; H L DuPont; A H West; J J Mathewson
Journal: Antimicrob Agents Chemother Date: 1983-10 Impact factor: 5.191

9. Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors.

Authors: P C Taylor; F D Schoenknecht; J C Sherris; E C Linner
Journal: Antimicrob Agents Chemother Date: 1983-01 Impact factor: 5.191

10. In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.

Authors: P Van der Auwera; B Scorneaux
Journal: Antimicrob Agents Chemother Date: 1985-07 Impact factor: 5.191

5 in total

1. Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis.

Authors: W Ziering; P McElvaine
Journal: Infection Date: 1998 Jan-Feb Impact factor: 3.553